<DOC>
	<DOCNO>NCT01465165</DOCNO>
	<brief_summary>Several line evidence support existence underlie abnormality brain energy metabolism may play key role biology mood disorder . The current study utilizes two distinct complementary imaging technique , FDG PET multinuclear MRS , good understand nature metabolic abnormality major depressive disorder ( MDD ) . The investigator hypothesize individual depression increase metabolic activity measure PET certain brain region involve mood regulation , metabolic activity inefficient base MRS finding . For study , investigator study 10 medication-free , currently depress participant recurrent MDD , 10 depress participant recurrent MDD currently take antidepressant medication , 20 healthy control participant match depressed participant age gender . Depressed healthy participant undergo one PET scan one MRS scan session .</brief_summary>
	<brief_title>Use Multiple Brain Imaging Modalities ( PET MRS ) Identify Metabolic Abnormalities Major Depression</brief_title>
	<detailed_description />
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Antidepressive Agents</mesh_term>
	<criteria>Meet DSMIV TR criterion MDD , Recurrent MontgomeryAsberg Depression Rating Scale ( MADRS ) score &gt; 18 Any coexist psychiatric illness generalize anxiety disorder , panic disorder , social/specific phobias Any history substance dependence Substance abuse within past 6 month Significant risk suicide , define score &gt; 4 item 10 MADRS clinical judgment study physician Any significant medical neurological condition likely impact central nervous system and/or affect result MRS PET image For subset unmedicated MDD patient , psychotropic medication within 4 week prior scan . For subgroup medicate patient , may take stable dose ( i.e. , dose least 4 week time scan ) standard antidepressant medication , may take psychotropic medication . Inability give inform consent Contraindication MRI ( e.g. , pacemaker , ferromagnetic implant body )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>Depression</keyword>
	<keyword>Positron emission tomography</keyword>
	<keyword>Magnetic resonance spectroscopy</keyword>
	<keyword>glucose metabolism</keyword>
	<keyword>ATP</keyword>
	<keyword>phosphocreatine</keyword>
</DOC>